Clinical evaluation of an Ayurvedic therapy– Sutashekhara Rasa and Brihat Jeevakadya Taila Nasya in the management of Ardhavabhedaka (Migraine)
DOI:
https://doi.org/10.47552/ijam.v6i2.577Keywords:
Ardhavabhedaka, Brihat Jeevakadya Taila, Migraine, Sutashekhara Rasa.Abstract
Ardhavabhedaka-hemicranial headache is a psychosomatic disorder: later replaced by migraine a Greek word "half of the head" because the pain of migraine often occurs on one side(classical Migraine) may affect the entire head. The term "migraine" refers to a syndrome of vascular pathology of the cranial blood vessels and is one of the commonest headache encountered in clinical practise. The survey results suggested that both patients and physicians believe migraine treatment is elusive and that patients are becoming increasingly frustrated and dissatisfied with treatment outcomes. Clinically, it is a Rakta/Pitta dominant disease;andAcharya Charaka opined that the vitiated Doshas after reaching Shirah vitiates Rakta (Rasavaha and Raktavaha Srotas) there to produce Shiro Roga (headache). Its diagnosis is based on mainly clinical history. For the present study, it was planned to compare the result between Brihat Jeevakadhya Taila Nasyaand Sutashekhara Rasa orally (Pitashamaka, Raktashodhaka, Deepana etc.) in Treatment Trial group and Flunarizine in Control group. The overall effect of therapy showed that in Trial group 80. 00% patients had marked improvement, followed by moderate improvement in 13. 33% and complete improvement in 6. 67%. In control group marked and moderate improvement was seen in 60. 00% and 33. 33% respectively; and 6. 67% had mild improvement. No any adverse drug reaction was found during whole study. Total 30 patients were registered and from the results and observation which were received from this study it can be concluded that Trial group is showing better results in Ardhavabhedaka
Downloads
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
